Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E H Decloedt"'
Autor:
V Pillay-Fuentes Lorente, G Voigt, C E du Plessis, K Balme, C J Marks, E H Decloedt, C Stephen, H Reuter, R van Rensburg
Publikováno v:
South African Medical Journal, Vol 112, Iss 8 (2022)
Background. Ivermectin is an antiparasitic drug that has shown in vitro activity against COVID‑19. Clinical studies supporting ivermectin for COVID‑19 prevention and treatment are conflicting, with important limitations. Public support for iverme
Externí odkaz:
https://doaj.org/article/534e01961b754129af5a8bba54b34443
Autor:
V Pillay-Fuentes Lorente, R van Rensburg, M S Moolla, M McCaul, A Parker, J Taljaard, H Reuter, E H Decloedt
Publikováno v:
South African Medical Journal, Vol 112, Iss 7 (2022)
Background. An increased incidence of thromboembolic events in hospitalised COVID‐19 patients has been demonstrated despite the use of low‐molecular‐weight heparin (LMWH). Antiplatelet therapy prior to admission and early in the disease course
Externí odkaz:
https://doaj.org/article/607aaebf47724602a631773dbb101926
Autor:
E S W Jones, M Lesosky, M Blockman, S Castel, E H Decloedt, S L U Schwager, E D Sturrock, L Wiesner, B L Rayner
Publikováno v:
South African Medical Journal, Vol 107, Iss 10, Pp 887-891 (2017)
Background. Non-adherence to antihypertensives is a cause of ‘pseudo-treatment-resistant’ hypertension. Objective. To determine whether monitoring plasma amlodipine concentrations and inhibition of angiotensin-converting enzyme (ACE) can be adju
Externí odkaz:
https://doaj.org/article/2bfb9edc5c2343e5a6ef6e63f4100810
Autor:
U, Lalla, C F N, Koegelenberg, B W, Allwood, L N, Sigwadhi, E M, Irusen, A E, Zemlin, T E, Masha, R T, Erasmus, Z C, Chapanduka, H, Prozesky, J, Taljaard, A, Parker, E H, Decloedt, F, Retief, T P, Jalavu, V D, Ngah, A, Yalew, J L, Tamuzi, N, Baines, M, McAllister, A, Zumla, P S, Nyasulu
Publikováno v:
African journal of thoracic and critical care medicine. 27(4)
The second wave of coronavirus disease 2019 (COVID-19), dominated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant, has been reported to be associated with increased severity in South Africa (SA).To describe and compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e979f98cc50868b5dd96214923b0df39
https://pubmed.ncbi.nlm.nih.gov/35359698
https://pubmed.ncbi.nlm.nih.gov/35359698
Autor:
E H, Decloedt, J, Mwansa-Kambafwile, J-S, van der Walt, H, McIlleron, P, Denti, P, Smith, L, Wiesner, M, Rangaka, R J, Wilkinson, G, Maartens
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 17(3)
Isoniazid preventive therapy (IPT) is recommended in patients on antiretroviral treatment. Isoniazid (INH) inhibits CYP3A4, which metabolises nevirapine (NVP). Administration of INH may cause higher NVP concentrations and toxicity. We studied the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dad59abef516a5a695613b71200eca93
https://pubmed.ncbi.nlm.nih.gov/23407222
https://pubmed.ncbi.nlm.nih.gov/23407222